Radiation Oncology/Therapy: Page 105

ITG, Bruce Power team up on lutetium-177 production

By AuntMinnie.com staff writers

German firm Isotope Technologies Garching (ITG) and nuclear reactor operator Bruce Power have signed a memorandum of understanding for the joint production of the radioisotope lutetium-177.

July 5, 2018

RaySearch brings RayStation to Kobe Proton Center

By AuntMinnie.com staff writers

Radiation therapy software developer RaySearch Laboratories has delivered its RayStation software to Kobe Proton Center in Kobe, Japan.

July 4, 2018

Augmenix brings SpaceOAR hydrogel to Japan

By AuntMinnie.com staff writers

Prostate radiation therapy device developer Augmenix said the Japanese Ministry of Health, Labor, and Welfare has added the firm's Spacing Organs at Risk (SpaceOAR) hydrogel spacer to the national reimbursement program for all men undergoing prostate cancer radiotherapy in Japan.

July 2, 2018

Novel nanoSPECT/CT radionuclide could aid cancer therapy

By Wayne Forrest

Swedish and Dutch researchers are reporting early progress in combining nanoSPECT/CT with a novel pretargeted radionuclide therapy for cancer that so far is nontoxic to the kidneys, according to a preclinical study published in the July issue of the Journal of Nuclear Medicine.

July 2, 2018

SNMMI: Early prostate cancer therapy extends lives

By Erik L. Ridley

PHILADELPHIA - Providing lutetium-177 prostate-specific membrane antigen radioligand therapy earlier to patients with metastatic prostate cancer can extend lives, according to research presented on Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.

June 26, 2018

RaySearch, Mevion win Georgetown install

By AuntMinnie.com staff writers

MedStar Georgetown University Hospital in Washington, DC, has begun treating patients with RaySearch Laboratories' RayStation treatment planning system in combination with Mevion Medical Systems' Hyperscan pencil-beam scanning system.

June 25, 2018